Chromatin Remodeling Proteins in Epilepsy: Lessons From CHD2-Associated Epilepsy

Area of Science:

• Genetics and Molecular Biology
• Neuroscience
• Epigenetics

Background:

• Chromodomain helicase DNA-binding (CHD) proteins are ATP-dependent chromatin remodelers crucial for gene expression regulation.
• Pathogenic variants in several CHD genes, including CHD2, are associated with neurodevelopmental disorders like autism spectrum disorder, intellectual disability, and epilepsy.
• CHD2 variants specifically cause developmental epileptic encephalopathy (DEE), but the underlying mechanisms remain poorly understood.

Purpose of the Study:

• To review the phenotypic spectrum associated with pathogenic CHD2 variants in humans.
• To discuss current animal models used to study CHD2 deficiency.
• To explore the role of CHD2 in key neurodevelopmental processes and its potential contribution to DEE.

Main Methods:

• Literature review of patient phenotypes associated with CHD2 variants.
• Analysis of existing animal models for CHD2 deficiency.
• Discussion of CHD2's function in cellular processes including proliferation, neurogenesis, neuronal differentiation, chromatin remodeling, and DNA repair.

Main Results:

• CHD2 is uniquely implicated in brain development, as its disruption leads to brain-restricted phenotypes.
• CHD2 plays critical roles in proliferation, neurogenesis, neuronal differentiation, chromatin remodeling, and DNA repair.
• Defects in these biological mechanisms due to CHD2 depletion are hypothesized to underlie neurodevelopmental disorders, particularly epilepsy.

Conclusions:

• Pathogenic variants in CHD2 are a significant cause of developmental epileptic encephalopathy.
• CHD2's specific role in the brain highlights its importance in neurodevelopment.
• Further research into CHD2 function and the impact of its depletion is crucial for understanding and potentially treating DEE and related neurodevelopmental disorders.